Bone Marrow Transplant Not the HIV Cure Many Hoped

Two men with HIV who underwent bone marrow transplants for the treatment of Hodgkin's lymphoma and then appeared to be free of HIV are again showing signs of the virus.

Disappointment was felt all around following the revelation that the two men, whose identities have not been made public, were found to be carrying the virus again.

Virus temporarily undetectable

One man underwent a transplant in 2008 and the other had his in 2010.

Approximately eight months after receiving the transplant, the HIV virus was undetectable in both men. Nonetheless, their doctors kept them on antiretroviral therapy until earlier this year, when both men came off the daily medication.

Unfortunately, one patient showed signs of the virus 12 weeks later and the other showed signs 32 weeks later. Fortunately both men are said to be doing well.

A case of genetic resistance

Thus far only one individual appears to have been cured of the virus: American Timothy Brown, who was HIV-positive and then diagnosed with leukemia. He underwent a bone marrow transplant and has shown no signs of the virus in the six years since.

The difference between the men appears to be the donor cells. In Timothy Brown, the donor cells had a genetic resistance to HIV because they lacked the CCR5 receptor, and it appears to have conferred this status to Brown. The donors for the other two men carried the receptor, known as a gateway for the virus to get inside the cells.

Despite the disappointment, scientists remain upbeat, claiming to have learned a substantial amount of information about the virus from these patients.

Source: AP

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...